| 13 June 2017 | Management of sulfonylurea treated monogenic diabetes in pregnancy: implications of placental Glibenclamide transfer | Shepherd, M; Brook, AJ; Chakera, AJ; et al. |
| 24 May 2016 | Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder. | Clissold, RL; Shaw-Smith, C; Turnpenny, P; et al. |
| 3 September 2016 | Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes. | Williams, GM; Long, AE; Wilson, IV; et al. |
| 31 March 2016 | Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes | Babiker, T; Vedovato, N; Patel, K; et al. |
| 2012 | The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy | Urbanek, M; Hayes, MG; Lee, H; et al. |
| 1 May 2010 | Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight | Freathy, RM; Mook-Kanamori, DO; Sovio, U; et al. |
| 7 February 2017 | Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes | Day, JO; Flanagan, SE; Shepherd, MH; et al. |
| 28 April 2016 | Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis. | Hope, SV; Wienand-Barnett, S; Shepherd, M; et al. |
| 17 March 2017 | Precision diabetes: learning from monogenic diabetes | Hattersley, AT; Patel, KA |
| 5 October 2014 | Defining the role of common variation in the genomic and biological architecture of adult human height. | Wood, AR; Esko, T; Yang, J; et al. |
